Germline Testing in Prostate Cancer: Implementation and Disparities of Care
JCO Oncology Practice · 2023-05 · 19 (5) · 221-223
DOI: 10.1200/op.22.00804 ↗Kurz gefasst
Editorial in der Zeitschrift JCO Oncology Practice, 2023-05. Verfasst von Landon C Brown und 1 weiteren Autor:innen. Beteiligte Einrichtung: Levine Cancer Institute, Atrium Health, Charlotte, NC. Hauptthemen laut MEDLINE: Prostatic Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 13 Literaturangaben. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Levine Cancer Institute, Atrium Health, Charlotte, NC.
- Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC.
ORCID-Profile: Landon C Brown, Andrew J Armstrong
Förderung
- NCI NIH HHS
Zitieren
APA
Brown, L. C., & Armstrong, A. J. (2023). Germline Testing in Prostate Cancer: Implementation and Disparities of Care. JCO Oncology Practice, 19(5), 221-223. https://doi.org/10.1200/op.22.00804
Vancouver
Brown LC, Armstrong AJ. Germline Testing in Prostate Cancer: Implementation and Disparities of Care. JCO Oncology Practice. 2023;19(5):221-223. doi:10.1200/op.22.00804
BibTeX
@article{Brown2023,
author = {Brown, Landon C and Armstrong, Andrew J},
title = {Germline Testing in Prostate Cancer: Implementation and Disparities of Care},
journal = {JCO Oncology Practice},
year = {2023},
volume = {19},
number = {5},
pages = {221--223},
doi = {10.1200/op.22.00804}
}
EUVIMED